Jack A. Khattar, President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 119,800 shares at $50.55 ($6.1M) on 2025-10-09, disclosed to the SEC on 2025-10-10.
Scheduled sale ($6.1M) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.55 | 58,371 | $3.0M | 48.7% |
| 2 | $50.55 | 58,371 | $3.0M | 48.7% |
| 3 | $51.46 | 1,529 | $79K | 1.3% |
| 4 | $51.46 | 1,529 | $79K | 1.3% |
| Total | $50.57 avg | 119,800 | $6.1M | 100% |
| Filing → |
| SUPN | SELL | 2025-10-02 | $3.9M | — | Filing → |
| SUPN | SELL | 2025-10-01 | $414K | — | Filing → |
| SUPN | SELL | 2025-09-30 | $983K | — | Filing → |